Publication bias in situ

被引:60
作者
Phillips C.V. [1 ,2 ,3 ]
机构
[1] Ctr. Philos., Hlth./Plcy. Sci., Inc.
[2] Mgmt. Plcy. and Comm. Hlth. Division, Univ. of Texas Sch. of Public Health, RAS E-311, Houston, TX 77225
[3] Ctr. Clin. Res./Evidence-Based Med., University of Texas Medical School, Houston, TX
关键词
Publication Bias; Selective Reporting; Multiple Hypothesis Testing; Plain Language; File Drawer;
D O I
10.1186/1471-2288-4-20
中图分类号
学科分类号
摘要
Background: Publication bias, as typically defined, refers to the decreased likelihood of studies' results being published when they are near the null, not statistically significant, or otherwise "less interesting." But choices about how to analyze the data and which results to report create a publication bias within the published results, a bias I label "publication bias in situ" (PBIS). Discussion: PBIS may create much greater bias in the literature than traditionally defined publication bias (the failure to publish any result from a study). The causes of PBIS are well known, consisting of various decisions about reporting that are influenced by the data. But its impact is not generally appreciated, and very little attention is devoted to it. What attention there is consists largely of rules for statistical analysis that are impractical and do not actually reduce the bias in reported estimates. PBIS cannot be reduced by statistical tools because it is not fundamentally a problem of statistics, but rather of non-statistical choices and plain language interpretations. PBIS should be recognized as a phenomenon worthy of study - it is extremely common and probably has a huge impact on results reported in the literature - and there should be greater systematic efforts to identify and reduce it. The paper presents examples, including results of a recent HIV vaccine trial, that show how easily PBIS can have a large impact on reported results, as well as how there can be no simple answer to it. Summary: PBIS is a major problem, worthy of substantially more attention than it receives. There are ways to reduce the bias, but they are very seldom employed because they are largely unrecognized.
引用
收藏
相关论文
共 14 条
[1]  
Alderson P., Green S., Cochrane Collaboration Open Learning Material for Reviewers
[2]  
Olsen O., Gotzsche P.C., Cochrane review on screening for breast cancer with mammography, Lancet, 358, 9290, pp. 1340-1342, (2001)
[3]  
Hahn S., Williamson P.R., Hutton J.L., Investigation of within-study selective reporting in clinical research: Follow-up of applications submitted to a local research ethics committee, J Eval Clin Pract, 8, pp. 353-359, (2002)
[4]  
Hahn S., Williamson P.R., Hutton J.L., Garner P., Flynn E.V., Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies, Stat Med, 19, pp. 3325-3326, (2000)
[5]  
Light R.J., Pillemer D.B., Summing Up. The Science of Reviewing Research, (1984)
[6]  
Egger M., Davey Smith G., Schneider M., Minder C., Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, pp. 629-634, (1997)
[7]  
Pollack A., Altman L.K., Large trial finds AIDS vaccine fails to stop infection, New York Times, (2003)
[8]  
Altman L.K., Official Hopes to explain AIDS vaccine disparities, New York Times, (2003)
[9]  
HIV gp120 vaccine - VaxGen: AIDS-VAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen, Drugs RD, 4, 4, pp. 249-253, (2003)
[10]  
Cohen J., AIDS vaccine results draw investor lawsuits, Science, 299, (2003)